Dec 3-5, 2012 | West Palm Beach, Fl
The Genetics Policy Institute has partnered with leading academic institutions to create the most influential and important gatherings in the field by bringing together leaders in research, business, advocacy, finance, law and ethics to chart the future of regenerative medicine.
The World Stem Cell Summit agenda is developed with one goal in mind: to deliver cures. To do this, we must align patient advocacy, industry, science, policy and funding. This year, at our 8th annual World Stem Cell Summit, we are focused on translational solutions, bringing together the brightest minds from all stakeholder groups. It’s an experience you won’t want to miss.
More than 1,200 attendees are expected from 25 countries. Prominent industry leaders, scientists, clinicians, students, regulators, policymakers, patient advocates, philantropists, economic development officers and experts in law and ethics join together to advance our field.
Featuring more than 150 renowned international speakers and 65 hours of in-depth programming, the World Stem Cell Summit unites, educates, and harmonizes the global stem cell community. The 2012 World Stem Cell Summit’s interdisciplinary agenda is an engine for discovery, funding and commercialization, exploring the field’s most pressing topics with four tracks:
• Translation and Regulation
• Commercialization and Reimbursements
• Advocacy/Consumer Safety
This year, panels will address advancing treatments for specific diseases and conditions including: cancer, diabetes, HIV/AIDS, cardiovascular disease, spinal cord injury, paralysis, multiple sclerosis, ALS, Parkinson’s, eye diseases and others.
Speakers & Program Participants (See All)